Dotmatics (FKA Insightful Science GraphPad)
AcquiredConnect science, data, and decision-making
San Diego, United States · Founded 2005 · $11.3M raised
- Headquarters
- San Diego, California
- Employees
- 501–1000
- Founded
- 2005
- Business Model
- B2B
- Website
- dotmatics.com
- Total Funding
- $11.3M
- Last Round
- $3.8M SeedMar 2021
- Rounds
- 3
- Acquired by
- SiemensApr 2025
About
Dotmatics is a scientific R&D software platform used by over 2 million scientists across 10,000+ organizations globally. Founded in 2005, the company offers an integrated suite of tools spanning biology, chemistry, and materials science — including SnapGene, Geneious, GraphPad Prism, and LabArchives — unified under its AI-native Luma platform for multimodal scientific data management, workflow automation, and decision-making. Dotmatics serves leading pharmaceutical companies, biotechs, chemical manufacturers, and academic institutions. The company was acquired by Siemens in a $5.1 billion deal to strengthen Siemens' position in AI-powered life sciences R&D software.
Summary
Dotmatics (FKA Insightful Science GraphPad) is a Biotech company based in San Diego, United States, founded in 2005. It has raised $11.3M in total across 3 rounds, most recently a $3.8M Seed round in Mar 2021. Investors include Insight Partners, Siemens AG and Scottish Equity Partners.
Tech & App Stack
7 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Apr 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...